Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. UTHR
UTHR logo

UTHR

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

UTHR News

United Therapeutics Corporation Ranked Top Stock by Renaissance Technologies

22h agoYahoo Finance

United Therapeutics' Tyvaso Shows Positive Results for Lung Fibrosis

May 19 2026stocktwits

Tyvaso Shows Significant Efficacy in Phase 3 IPF Study

May 18 2026Newsfilter

Renaissance Technologies Q1 2026 Performance Analysis

May 18 2026seekingalpha

United Therapeutics' Drug Significantly Reduces Risk in Pulmonary Arterial Hypertension

May 18 2026seekingalpha

Ralinepag Achieves Breakthrough Results in Pulmonary Arterial Hypertension Study

May 17 2026Newsfilter

United Therapeutics Q1 Results Miss Expectations but Market Reacts Positively

May 16 2026Yahoo Finance

FDA Approves First Human Clinical Trial of Pig Heart

May 15 2026Newsfilter

First-Ever Collaboration for Space-Based Drug Development Announced

May 13 2026Newsfilter

United Therapeutics Explores Microgravity Drug Development with Varda Space Industries

May 13 2026seekingalpha

United Therapeutics Presents New Research Data at ATS Conference

May 11 2026Newsfilter

Latest Wall Street Ratings and Outlook

May 07 2026CNBC

United Therapeutics Q1 2026 Earnings Call Insights

May 06 2026seekingalpha

MannKind Partners with United Therapeutics for New Drug Development

May 06 2026stocktwits

MannKind and United Therapeutics Expand Collaboration Agreement

May 06 2026seekingalpha

United Therapeutics Q1 Earnings Miss Expectations

May 06 2026seekingalpha